Clinical TrialID 137
A New Supplement for the Immune Response to HPV Infection
NCT02263378
HPV Infection
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 137
- Evidence Id
- 137
- Core Evidence Id
- 137
- Source Clinical Trial Id
- 132
- Herb2 Clinical Trial Id
- HBCT000132
- Nct Id
- NCT02263378
- Title
- A New Supplement for the Immune Response to HPV Infection
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- HPV Infection
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: ellagic acid + annona muricata
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- Female
- Age
- Adult
- Enrollment
- 60
- Outcome Measure
- variation of onco suppressor protein expression from basal values. The expression variations are represented by the different percentage of positive cells, 6 months
- Sponsor Collaborator
- University of Messina
- Funded By
- OTHER
- Location
- Other Id
- OASIT-K
- Start Date
- 2014-09
- Primary Completion Date
- 2016-03
- Completion Date
- 2016-03
- First Posted
- 2014-10-13
- Results First Posted
- Last Update Posted
- 2016-05-24
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02263378
- Title Cn
- Title En
- A New Supplement for the Immune Response to HPV Infection
- Bilingual Status
- semi_complete